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The Diagnostic and Statistical Manual of Mental 
Disorders Fifth Edition (DSM-5) includes the 
category, “neurodevelopmental disorders”, which 
includes intellectual disabilities, communication 
disorders, autism spectrum disorder (ASD), 
attention-deficit/hyperactivity disorder (ADHD), 
specific learning disorder, and motor disorders (1). 
Grouping this set of disorders into the new 
neurodevelopmental disorders category is useful 
since is puts together a number of conditions related 
to atypical neurodevelopment, which are most often 
identified during childhood, and can frequently co-
occur. The DSM-5 gives clear descriptions of the 
individual neurodevelopmental syndromes, which 
are useful in classifying individuals for clinical and 
research purposes. However, the DSM-5 does not 
adequately address the issue of multiple co-occurring 
neurodevelopmental problems, especially in cases 
where multiple subthreshold neurodevelopmental 
symptoms occur in an individual. The DSM-5 does 
describe a number of “other specified” and 
“unspecified” neurodevelopmental diagnoses, which 
can be used for subthreshold or unclear cases with 
associated impairment, but some of these 
descriptions are problematic because they suggest 
that the diagnoses should not be used if the 
individual meets full criteria for any diagnosis in the 
entire neurodevelopmental disorders diagnostic 
class. This could discourage clinicians from 
providing a full diagnostic description in cases where 
multiple neurodevelopmental problems co-occur. 
The example of ADHD classification is particularly 
important to consider. As in the previous version of 
the manual, DSM-5 ADHD requires that an 
individual has either six of nine listed inattentive 
symptoms or six of nine hyperactive/impulsive 
symptoms in order to meet the full diagnostic 
criteria. Depending on whether they meet the 
symptom count threshold in just one or both of the 
above two symptom domains, individuals are 
classified as having the predominantly inattentive 
presentation, predominantly hyperactive/impulsive 
presentation, or the combined presentation (1). As 
noted in existing literature (2), this is problematic in 
the case of clinically impaired individuals who have 
six or more total symptoms but have less than six 
symptoms in each of the two domains. During the 
process of developing DSM-5 diagnostic criteria, it 
was suggested that an ADHD “not elsewhere 
classified” diagnosis could be used for such 
individuals (3). The need for this option is supported 
by research suggesting that individuals with 
subthreshold symptoms in both symptom domains 
may be more impaired than those with a similar 
number of total symptoms, but in just one of the two 
symptom domains (2). Although the final version of 
DSM-5 does not use the term “ADHD not elsewhere 
classified”, it does include “Other Specified 
Attention-Deficit/Hyperactivity Disorder” (for 
cases where the clinician specifies why full ADHD 
criteria are not met) and “Unspecified Attention-
Deficit/Hyperactivity Disorder” (to be used if the 
clinician chooses not to specify the reason full criteria 
are not met). The other specified ADHD category 
seems particularly appropriate for individuals with 
symptoms in both symptom domains who fail to 
meet the symptom count cutoff in either domain. 
Such individuals can be described as having a mild 
combined presentation of ADHD, a category which 
has been supported by latent class analysis of ADHD 
symptoms, and which (along with severe combined 
and severe inattentive latent class subtypes) is 
associated with significant impairment (4). The 
problem is that within the DSM-5 descriptions for 
other and unspecified ADHD diagnoses, the 
wording suggests these categories should not be used 
if the individual meets full criteria for any 
neurodevelopmental diagnosis (1). If strictly 
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followed, this means that a child with a diagnosis of 
intellectual disability, autism spectrum disorder, any 
communication disorder (even just a speech sound 
disorder), specific learning disorder, developmental 
coordination disorder, stereotypic movement 
disorder, or tic disorder cannot be given the 
diagnosis of other or unspecified ADHD simply 
because of their other neurodevelopmental disorder 
diagnosis. In other diagnostic classes, such as 
depressive disorders, it may make sense to reserve 
other and unspecified diagnosis labels for those who 
do not meet full criteria for any DSM-5 syndrome in 
the same class, but in the case of 
neurodevelopmental disorders, it is useful and 
important to be able to diagnose subthreshold but 
clinically impairing neurodevelopmental problems in 
multiple areas, so that each neurodevelopmental 
problem can be monitored over time and treated 
when appropriate.  
Given the high degree of phenotypic and genetic 
overlap among various neurodevelopmental 
symptoms and diagnoses (5, 6, 7, 8, 9), the presence 
of one neurodevelopmental disorder should make 
clinicians alert for co-occurring full syndrome or 
subthreshold neurodevelopmental problems in the 
same child, which may also need to be diagnosed and 
addressed. Hierarchical systems (such as ASD 
diagnosis disqualifying an individual from having an 
ADHD diagnosis in previous versions of the DSM) 
and symptom count cutoffs can be problematic when 
describing developmental deviations which can 
occur in various combinations and with differing 
severity. Research studies of neurodevelopmental 
disorders often focus on one disorder at a time, and 
may exclude individuals with another co-occurring 
neurodevelopmental disorder, but this leaves us with 
a relative lack of information regarding how to treat 
individuals with co-occurring neurodevelopmental 
disorders. Alternate methods of describing complex 
neurodevelopmental syndromes may be appropriate. 
For example, Gilger and Kaplan have suggested 
using the term “atypical brain development” and 
then specifying the child’s strengths and weaknesses 
(5). Gillberg has suggested the term “Early 
Symptomatic Syndromes Eliciting Neurodevelop-
mental Clinical Examinations” (ESSENCE) to 
describe neurodevelopmental syndromes which 
commonly co-occur and warrant comprehensive 
neurodevelopmental assessment (8). Although it may 
be more difficult to sort out mechanisms when 
studying complex cases with symptoms in multiple 
areas, it is important to include neurodevelop-
mentally complex cases in research, so that we will 
know how various neurodevelopmental symptoms 
interact and whether co-occurrence of multiple 
problems warrants different approaches to 
treatment. Some progress has been made in 
treatment studies of co-occurring ASD and ADHD 
(9), but further work is needed in this area, and in the 
study of other combinations of neurodevelopmental 
disorders. Future studies should bring improved 
methods of classifying and treating complex 
neurodevelopmental syndromes. 
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